British pharmaceutical firm GlaxoSmithKline (GSK) has reached an exclusive agreement with Chongqing Zhifei Biologic...
The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) and Japan-based Olympus Corporation...
Dr Deckster Tonny SAVADYE, CEO of Zimbabwe National Biotechnology Authority (NBA), and Dr Yang Yili, Internati...
A new antibiotic drug developed by a research team from the Department of Chemistry at The University of Hong Kong (HKU)...
China-based BGI Genomics, an integral part of BGI Group, has signed a Memorandum of Understanding (MoU) with t...
US-based pharmaceutical company Pfizer has announced the availability of Rimegepant in Hong Kong, the first market ...
Singapore headquarterd biopharmaceutical company DotBio, excelling in antibody therapeutic modalities announced tha...
Insilico Medicine has garnered attention for its innovative utilisation of artificial intelligence (AI) in drug discover...
WuXi Vaccines, a leading contract development and manufacturing organisation (CDMO) focused on vaccine discovery, develo...
The Chinese University of Hong Kong (CUHK) recently received a donation of HK$30 million from Li Ka-shing to support the...
Everest Medicines has entered into a collaboration and license agreement with Kezar Life Sciences to develop and commerc...
China-based startup Canton Biologics recently completed a Series C financing round exceeding 300 million yuan. This roun...
Recognising the long-term needs of the biopharma industry in China and Asia-Pacific, global life sciences leader Cytiva ...
China-based startup Cure Genetics and Frametact, founded by a molecular neuroscience research team at The...
Electronic devices that can be attached to the skin or even implanted in the body will become more and more prevalent in...
Clover Biopharmaceuticals has announced the launch of AdimFlu-S (QIS) in mainland China, where it is the only imported q...
Singapore-based Genesis MedTech, a leading medical device company, has announced that its absorbable sutures with antiba...
Grit Biotechnology has announced the completion of a Series B financing round, raising over $60 million. The investment ...
